Table 2.
Clinical factors in progression of arteriosclerosis
| Parameter | DSA-Positive |
DSA-Negative |
||||
|---|---|---|---|---|---|---|
| No. | Δcv Gradea | P | No. | Δcv Gradea | P | |
| Donor age | ||||||
| ≤50 years | 20 | 0.45 | NS | 20 | 0.30 | NS |
| > 50 years | 20 | 0.45 | 39 | 0.21 | ||
| Recipient age | ||||||
| ≤50 years | 26 | 0.46 | NS | 31 | 0.25 | NS |
| > 50 years | 14 | 0.39 | 27 | 0.11 | ||
| BP | ||||||
| normotensiveb | 20 | 0.35 | NS | 18 | 0.30 | NS |
| hypertensive | 20 | 0.49 | 37 | 0.06 | ||
| Acute cellular rejection (morphologic) | ||||||
| present | 4 | 0.13 | NS | 8 | 0.50 | NS |
| absent | 36 | 0.43 | 51 | 0.14 | ||
NS, not significant.
aΔ cv grade, increment of cv score between 3- and 12-month biopsies.
bGroup includes those normotensive on medication.